Iqvia Holdings (IQV) Non-Current Deferred Tax Liability (2011 - 2026)
Iqvia Holdings (IQV) posted Non-Current Deferred Tax Liability of $173.0 million for Q2 2026, up 8.81% sequentially from $159.0 million in Q1 2026, and down 19.91% YoY from $216.0 million in Q2 2025.
Iqvia Holdings (IQV) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Iqvia Holdings has reported Non-Current Deferred Tax Liability for 16 years, with the latest figure at $173.0 million in Q2 2026.
- Quarterly Non-Current Deferred Tax Liability fell 19.91% year-over-year to $173.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $173.0 million (down 19.91% YoY) and the FY2025 annual result came in at $179.0 million, down 75.78% from the prior year.
- Non-Current Deferred Tax Liability climbed to $173.0 million in Q2 2026 per IQV's latest filing, from $159.0 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $976.0 million in Q4 2022 and troughed at $128.0 million in Q3 2024.
- A 5-year average of $373.1 million and a median of $290.5 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability soared 88.55% in 2022, then tumbled 75.78% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $976.0 million in 2022, then dropped by 21.52% to $766.0 million in 2023, then dropped by 3.52% to $739.0 million in 2024, then sank by 75.78% to $179.0 million in 2025, then fell by 3.35% to $173.0 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $173.0 million, $159.0 million, and $179.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 173.00 Mn |
| Jun 30, 2026 | 173.00 Mn |
| Mar 31, 2026 | 159.00 Mn |
| Mar 31, 2026 | 159.00 Mn |
| Dec 31, 2025 | 179.00 Mn |
| Dec 31, 2025 | 179.00 Mn |
| Sep 30, 2025 | 207.00 Mn |
| Sep 30, 2025 | 207.00 Mn |
| Jun 30, 2025 | 216.00 Mn |
| Jun 30, 2025 | 216.00 Mn |
| Mar 31, 2025 | 197.00 Mn |
| Mar 31, 2025 | 197.00 Mn |
| Dec 31, 2024 | 739.00 Mn |
| Dec 31, 2024 | 739.00 Mn |
| Sep 30, 2024 | 128.00 Mn |
| Sep 30, 2024 | 128.00 Mn |
| Jun 30, 2024 | 149.00 Mn |
| Jun 30, 2024 | 149.00 Mn |
| Mar 31, 2024 | 164.00 Mn |
| Mar 31, 2024 | 164.00 Mn |